COPPER, 2 x 50 mL

    993305



    To access the documentation you must be registered

    Register


    Conformité européenne In vitro diagnostic product

    For in vitro determination of copper in serum or plasma.

    State Liquid
    Storage temp. +15/ +25 ºC
    Technique Colorimetric method

    PRINCIPLE

    In acid solution (pH 4.7), copper (II) is released from the ceruloplasmin protein and reduced to copper (I). The cuprous ion reacts with the 3,5 dibromo-2-pyridylazo-N-ethyl-N (-3-sulfopropyl) -aniline (3,5-diBr-PAESA), and forms a stable coloured complex, which is photometrically measured at 582 nm.

    The colour intensity is directly proportional to the concentration of copper ions present in the sample.

    DIAGNOSTIC USE

    Serum copper levels increase in hemochromatosis, biliary cirrhosis, leukemia, Hodgkins disease, anemia, rheumatoid arthritis, hypothyroidism, malignancy, collagen disease, among others.

    The serum copper decreases in Wilsons disease, Menkes syndrome, nephrotic syndrome and burns.

    The determination of levels of copper in the urine is used in the study of Wilsons disease (hepatolenticular degeneration).

    A single test result could not be used to make a clinical diagnosis. It should integrate clinical and laboratory data.